Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 公共衛生學院
  3. 環境衛生研究所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/36249
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor宋鴻樟
dc.contributor.authorHsiang-Jung Huangen
dc.contributor.author黃香榕zh_TW
dc.date.accessioned2021-06-13T07:54:54Z-
dc.date.available2010-08-04
dc.date.copyright2005-08-04
dc.date.issued2005
dc.date.submitted2005-07-23
dc.identifier.citation1. Dept.of Health. Cancer Registry Annual Report, Republic of China, 1995. Executive Yuan Dept. of Health, Taipei. 2001.
2. Dept.of Health. Health and Vital Statistics. Executive Yuan Dept. of Health, Taipei. 1993 and 2001.
3. NCI. Div. of Cancer Prevention and Control Cancer Statistics Review 1973-1988. U.S. NIH Pub No. 91-2789, Bethesda, MD.
4. Pienta KJ, Esper PS. Is dietary fat a risk factor for Prostate Cancer? J Nat1 Cancer Inst 85: 1538-40, 1993.
5. Talamini R, La Vecchia C, Decarli A, Negri E, Francise. Nutrition, social factors, and prostatic cancer in a Northern Italian. Br J Cancer 53: 817-21, 1986
6. Muir CS, Staszewski J: The epidemiology of prostatic cancer. Acta Oncologica 30: 133-140, 1991
7. Potts CL.: Cadmium proteinuria—the health of battery workers exposed to cadmium oxide dust. Ann Occup Hyg 8: 55-61, 1965
8. Kolonel L, Winkelstein W: Cadmium and prostatic carcinoma. Lancet Sep. 10, 566, 1977.
9. Armstrong BG, Kazantzis G: Prostatic cancer and chronic respiratory and renal disease in British cadmium workers: a case control study. Bri J Ind Med 42:540-545, 1985.
10. Lee JS, White KL: A review of the health effects of cadmium. Am J Ind Med 1: 307-317, 1980.
11. Greenwald P: The prostate. In: Scottenfeld D. Fraumeni JF ed.: Cancer epidemiology and prevention. P944, Philadelphia: WB Saunders, 1982.
12. Aronson KJ, Siemitatycki J., Dewar R, Gérin M: Occupational risk factors for prostate cancer: results from a case-control study in Montréal, Québec, Canada. Am J Epidemiol 143(4): 363-73, 1996.
13. Woolf, C.M: An investigation of the familial aspects of carcinoma of the prostate. Cancer 13: 739-744, 1960.
14. Bako G, Smith ESO, Hanson J, Dewar R: The geographical distribution of high cadmium concentrations in the environment and prostate cancer in Alberta. Can J Public Health 73: 92-96, 1982.
15. Thun MJ, Schnorr TM, Smith AB, Halperin WE, Lemen RA: Mortality among a cohort of U.S. cadmium production workers- an update. JNCI, 74: 325-33, 1985.
16. Garcia SA, Antona JF, Urrutia M. Geochemical prospection of cadmium in a high incidence area of prostate cancer, Sierra De Gata , Salamanca, Spain. Science of the Total Environment 116: 243-51, 1992.
17. Waalkes MP, Rehm S. Cadmium and Prostate Cancer. J Toxicol Environ Health 43: 251-69, 1994.
18. West DW, Slattery ML, Robison LM, French TK, Mahoney AW: Adult dietary intake and prostate cancer risk in Utah: A case-control study with special emphasis on aggressive tumors. Cancer Causes & Control 2: 85-94, 1991. (Abstract)
19. van der Gulden JW, Kolk JJ, Verbeek AL. Work environment and prostate cancer risk. Prostate 27: 250-7, 1995. (Abstract)
20. Elghany NA, Schumacher MC, Slattery ML, West DW, Lee JS: Occupation, cadmium exposure, and prostate cancer. Epidemiology 1: 107-15, 1990. (Abstract)
21. Webber MM: Selenium prevents the growth stimulatory effects of cadmium on human prostatic epithelium. Biochemical and Biophysical Research Communications 127: 871-877, 1985.
22. Feustel A, Wennrich R, Steiniger D, Klauss P: Zinc and cadmium concentration in prostatic carcinoma of different histological grading in comparison to normal prostate tissue and adenofibromyomatosis (BPH). Urol Res 10: 301-303, 1982.
23. Feustel A, Wennrich R, Dittrich H: Zinc, cadmium, and selenium concentrations in separated epithelium and stroma from tissues of different histology. Urol Res 15: 161-163, 1987.
24. Feustel A, Wennrich R: Determination of the distribution of zinc and cadmium in cellular fractions of BPH, normal prostatic cancers of different histologies by Atomic and laser absorption spectrometry in tissue Slices. Urol Res 12: 253-256, 1984.
25. Battersby S, Chandler JA, Morton MS: The effect of orally administered cadmium on the ultrastructure of the rat prostate. Urol Res 10: 123-130,1982.
26. Waalkes MP, Rehm S, Riggs CW, Bare RM, Devor DE, Poirier LA, Wenl ML, Henneman JR, Balaschak MS: Cadmium carcinogenesis in the male Wistar [Crl:(WI)BR] rats: dose-response analysis of tumor induction in the prostate and testes and at the injection site. Cancer Res 48: 4656-4663, 1988.
27. Waalkes MP, Rehm S, Riggs CW, Bare RM, Devor DE, Poirier LA, Wenl ML, Henneman JR: Cadmium carcinogenesis in the male Wistar [Crl:(WI)BR] rats: dose-response analysis of effects of zinc on tumor induction in the prostate and in the testes and at the injection site. Cancer Res 49: 4282-4288, 1988.
28. Adlercreutz H: Phytoestrogens: epidemiology and a possible role in cancer protection. Environ Health Perspect 103(Suppl 7): 103-112, 1995.
29. Ogunlewe JO, Osegbe DN: Zinc and cadmium concentration in indigenous blacks with normal, hypertrophic and malignant prostate. Cancer 63:1388-92, 1989.
30. 宋鴻樟:鎘、攝護腺特異抗原和攝護腺癌行政院國家科學委員會專題研究計劃成果(NSC 88-2314-B-002-050),台北,88。
31. 宋鴻樟:鎘、攝護腺特異抗原和攝護腺癌。行政院國家科學委員會專題研究計劃成果(NSC 89-2320-B-002-122),台北,89。
32. Waalkes MP, Rehm S: Carcinogenicity of oral cadmium in the male Wistar (WF/NCr) rat: effect of chronic diertary zinc deficiency Fundam Appl Toxicol 19: 512-520, 1992.
33. Waalkes MP, Rehm S, Perantoni AO, Coogan TP: Cadmium exposure in rats and tumours of the prostate. IARC Scientific Publications 118: 391-400, 1992.
34. Tariq MA, Fatima A: Concentrations of Cu, Cd, Ni, and Pb in the blood and tissues of cancerous persons in a Pakistani population. Sci Total Environ. 175: 43-48,1995.
35. Sung JFC, Lin RS, Pu YS, Chen YC, Chang HC, Lai MK: Risk factors for prostate cancer in Taiwan: a case-control study in a Chinese Population. Cancer 86:484-492,1999.
36. Chen YC, Sung FC, Lee MC: Association between dietary intake and blood and urine cadmium levels among men in Taiwan. Chin J Public Health (Taipei) 19: 203-213, 2000
37. Chen YC, Pu YS, Lin RS, Yang CY, Lai MK, Liu SH, Sung FC: Blood and urine cadmium levels in relation to demographic and life style in middle ages and the elderly men. Bull Environ Contamination Tocicol(in Press, 2000) .
38. Gyorkey F, Minn KW, huff JA, Gyorkey P: Zinc and magnesium in human Prostate Gland: Normal, Hyperplastic, and Neoplastic. Cancer Res 27:1348-1353, 1967
39. Tariq MA, Fatima A: Concentrations of Cu, Cd, Ni,andPb in the blood and tissues of cancerous persons in a Pakistaini population. Sci Total Environ.175:43-48,1995
40. Magdalena Brys, Agnieszka D. Nawrocka, Eugeniusz Miekos, Cezary Zydek, Marek Foksinski, Andrzej Barecki,Wanda M. Krajewska: Zinc and Cadmium Analysis in Human Prostate Neoplasms. Biological Trace Element Research.59:145-152,1997
41. Turker AR, Yusel M.Digestion method for flame AAS determination of transition metal canned tomato paste.JAAS 18:41-54,1997
42. Puchyr RF.,Bass DA.,Gajewski R., Calvin M., Marqoardt W.,Urek K.,Druyan ME.,Quig D.: Preparation of Hair for Measuremeny of Elements by Inductively Coupled Plasma-Mass Spectrometry(ICP-MS).Biological Trace Element Research.62:167,1998
43. Ghafoor M. Schuyten R. Bener A. Epidemiology of prostate cancer in United
Arab Emirates. [Journal Article] Medical Journal of Malaysia. 58:712-6, 2003 .
44. Druet-Cabanac M. Colombeau P. Preux PM. Paulhac P. Vergnenegre A. Dumas JP.
[Epidemiology of prostate cancer in the Limousin area]. [French] [Journal
Article] Progres en Urologie. 12:226-31, 2002 .
45. La Rosa F. Stracci F. Minelli L. Mastrandrea V. Epidemiology of prostate cancer
in the Umbria region of Italy: evidence of opportunistic screening effects.
[Journal Article] Urology. 62:1040-4, 2003 Dec.
46. Hsing AW, McLaughlin JK, Zheng W, Gao YT, Blot WJ. Occupation, physical activity,
and risk of prostate cancer in Shanghai, People's Republic of China. Cancer Causes
Control. 5:136-140,1994.
47. Krstev S, Baris D, Stewart P, Dosemeci M, Swanson GM, Greenberg RS, Schoenberg
JB, Schwartz AG, Liff JM, Hayes RB. Occupational risk factors and prostate cancer in
U.S. blacks and whites. Am J Ind Med. 34:421-43,1998.
48. Parker AS, Cerhan JR, Putnam SD, Cantor KP, Lynch CF. A cohort study of farming and
risk of prostate cancer in Iowa. Epidemiology. 1999 ;10(4):452-455.
49. Parent ME, Siemiatycki J. Occupation and prostate cancer. Epidemiol Rev.
2001;23(1):138-143.
50. Pagano F, Zattoni F, Vianello F, Pizza R, Capitanio G: Is there a relationship between
benign prostatic hyperplasia and prostatic cancer? Eur Urol 20:31-35,1991.
51. 蒲永孝,黃昭淵:認識前列腺癌。正中書局 醫學叢書系列 86年4月初版。
52. 蒲永孝:前列腺癌。中華民國外科醫學會 外科醫學叢書 第一篇 前列腺疾病之
第二章,1997 。
53. 張淑梅 :台灣南部地區前列腺癌相關危險因子之研究。高雄醫學大學碩士論文,
2003。
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/36249-
dc.description.abstract本研究以國家衛生研究院發行之全民健康保險資料庫歸人檔分析台灣1996年至2002年七年間攝護腺癌(prostate cancer,PCA)及良性攝護腺腫大(benign prostatic hyperplasia,BPH)患者的疾病率與醫療情況,並探討良性攝護腺腫大與攝護腺癌的關係。
本研究之重要研究結果如下:就醫院所在地來分析,攝護腺癌患者在台北地區就醫的比例最高,共有103人、佔45.98%;而攝護腺腫大患者在其他地區就醫的比例最高,共有2445人、佔43.13%。
1996-2002年七年間平均的地區別攝護腺癌年齡標準化盛行率由高而低依序是:台北市為35.3×10-5,高雄市為31.8×10-5,台中市為24.4×10-5,其他地區為28.5×10-5,與都市化程度成正相關。1996-2002年七年間平均的地區別良性攝護腺腫大粗盛行率由高而低依序是:其他地區為1011.0×10-5,台北市為813.8×10-5,高雄市為740.8×10-5,台中市為574.7×10-5。另外由邏輯氏迴歸求出居住在台北地區得攝護腺癌的勝算比是居住在其他地區的1.7倍(95%可信賴區間=1.3-2.3)。
本研究亦選擇世代研究法探討良性攝護腺腫大是否為攝護腺癌的危險因子,得到相對危險性15.7。另以邏輯式迴歸分析1996-2002年歸人檔資料探討良性攝護腺腫大與攝護腺癌的關係,結果得到良性攝護腺腫大患者得攝護腺癌的勝算比是非良性攝護腺腫大患者的19.0倍(95%可信賴區間=13.1-27.6)。提供流行病學的證據證明良性攝護腺腫大為攝護腺癌的危險因子ㄧ。但無法了解良性攝護腺腫大對攝護腺癌的致病機轉,因此需更進一步生物醫學的研究如、病理學細胞毒性、動物實驗才能釐清BPH對PCA的致病關係。
zh_TW
dc.description.abstractThis study analyze the morbidity、the utilization pattern and the relation of prostate cancer(PCA)and benign prostatic hyperplasia(BPH) in Taiwan. The study sample were selected from NHI Registry for Beneficiaries’ Database from 1996 to 2002.Major findings of this study are as followed: For PCA, Taipei is the highest rate to seek medical advice(103 persons, 45.98%);For BPH, other areas is the highest rate to seek medical advice(2445 persons, 43.13%).The age standardization prevail rate of PCA:Taipei is 35.3×10-5, Kaohsjung is 31.8×10-5, Taichung is 24.4×10-5 , other area is 28.5×10-5, it is positive correlation with the urbanization degree. .The age standardization prevail rate of BPH:Other area is 1011.0×10-5, Taipei is 813.8×10-5 , Kaohsjung is 740.8×10-5, Taichung is 574.7×10-5, in direct proportion with the hospital site. Cohort study and logistic regression was used to determine the relative risk of specific risk factors on prostate cancer risk. The significant risk factors and protective factors for prostate cancer in study were as follows: Living in Taipei had highter risk for prostate cancer(OR=1.7;95%CI=1.3-2.3);BPH history had highter risk for prostate cancer (RR=15.67;OR=19.0;95%CI=13.1-27.6). Offer the evidence of epidemiology but unable to understand that BPH rotates to the causing a disease machine of PCA .Some enviromental and life-style factors may have associated with prostate cancer risk. A better understanding about these biological mechanisms will be helpful to prevent from the development of prostate cancer in the future.en
dc.description.provenanceMade available in DSpace on 2021-06-13T07:54:54Z (GMT). No. of bitstreams: 1
ntu-94-R90844012-1.pdf: 366843 bytes, checksum: 931963d18a1453b7b18a811379856a46 (MD5)
Previous issue date: 2005
en
dc.description.tableofcontents第一章 緒論 1
第一節 研究背景 1
第二節 研究目的 4
第二章 文獻探討 5
第一節 攝護腺癌簡介 5
第二節 台灣地區攝護腺癌流行概況 22
第三章 研究設計與方法 27
第一節 研究假設 27
第二節 樣本及資料來源 28
第三節 資料處理與分析方法 30
第四章 研究結果 34
第一節 台灣地區1996-2002年攝護腺癌及良性攝護腺腫大盛行 概況 34
第二節 台灣地區1996-2002年攝護腺癌及良性攝護腺腫大就醫狀況 39
第三節 台灣地區1996-2002年攝護腺癌及良性攝護腺腫大醫療費用 51
第四節 台灣地區1996-2002年歸人檔攝護腺癌及良性攝護腺腫大關係 54
第五章 討論 62
參考文獻 68
dc.language.isozh-TW
dc.subject健保資料庫zh_TW
dc.subject攝護腺癌zh_TW
dc.subject良性攝護腺腫大zh_TW
dc.subject台灣zh_TW
dc.subjectTaiwanen
dc.subjectbenign prostatic hyperplasiaen
dc.subjectHealthcare Databaseen
dc.subjectProstate canceren
dc.title臺灣地區1996-2002年攝護腺癌發生和盛行比較zh_TW
dc.titleThe Incidence and Prevalence of Prostate Cancer in Taiwan Base on National Insurance Data from 1996 to 2002en
dc.typeThesis
dc.date.schoolyear93-2
dc.description.degree碩士
dc.contributor.oralexamcommittee林瑞雄,吳聰能
dc.subject.keyword攝護腺癌,良性攝護腺腫大,台灣,健保資料庫,zh_TW
dc.subject.keywordProstate cancer,benign prostatic hyperplasia,Taiwan,Healthcare Database,en
dc.relation.page73
dc.rights.note有償授權
dc.date.accepted2005-07-25
dc.contributor.author-college公共衛生學院zh_TW
dc.contributor.author-dept環境衛生研究所zh_TW
顯示於系所單位:環境衛生研究所

文件中的檔案:
檔案 大小格式 
ntu-94-1.pdf
  未授權公開取用
358.25 kBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved